Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

VACC

Vaccitech (VACC)

Vaccitech PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VACC
DateTimeSourceHeadlineSymbolCompany
11/07/20239:20AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VACCVaccitech PLC
06/21/20237:30AMGlobeNewswire Inc.Arbutus Doses First Patient in Additional Treatment Arm of Phase 2a Triple Combination Clinical Trial that Includes a PD-1 Monoclonal AntibodyNASDAQ:VACCVaccitech PLC
11/14/20226:30AMTipRanksAnalysts Are Bullish on These Healthcare Stocks: RAPT Therapeutics (RAPT), Vaccitech Plc (VACC)NASDAQ:VACCVaccitech PLC
11/08/20226:30AMTipRanksAnalysts Are Bullish on These Healthcare Stocks: Cassava Sciences (SAVA), Apellis Pharmaceuticals (APLS)NASDAQ:VACCVaccitech PLC
11/01/20226:25AMTipRanksH.C. Wainwright Reaffirms Their Buy Rating on Vaccitech Plc (VACC)NASDAQ:VACCVaccitech PLC
10/31/20228:00AMGlobeNewswire Inc.Vaccitech Doses First Patients in HBV003, a Phase 2b Clinical Trial of VTP-300 immunotherapeutic candidate for Chronic HBV PatientsNASDAQ:VACCVaccitech PLC
10/03/20224:30PMGlobeNewswire Inc.Vaccitech to Present at Upcoming October Investor & Scientific ConferencesNASDAQ:VACCVaccitech PLC
09/07/20224:01PMGlobeNewswire Inc.Vaccitech to Present at Upcoming September Investors ConferencesNASDAQ:VACCVaccitech PLC
08/11/20226:25AMTipRanksH.C. Wainwright Reaffirms Their Buy Rating on Vaccitech Plc (VACC)NASDAQ:VACCVaccitech PLC
08/09/20224:15PMGlobeNewswire Inc.Vaccitech Reports Second Quarter 2022 Financial Results and Recent Corporate DevelopmentsNASDAQ:VACCVaccitech PLC
07/07/20224:15PMGlobeNewswire Inc.Vaccitech to Present at the William Blair Biotech Focus Conference 2022NASDAQ:VACCVaccitech PLC
06/23/20226:16AMTipRanksH.C. Wainwright Reaffirms Their Buy Rating on Vaccitech Plc (VACC)NASDAQ:VACCVaccitech PLC
06/22/20226:00AMGlobeNewswire Inc.Vaccitech’s VTP-300 induced sustained reductions of surface antigen in patients with chronic hepatitis B both as a monotherapy and in combination with a single low dose of anti-PD-1NASDAQ:VACCVaccitech PLC
06/07/20228:05AMTipRanksAnalysts Offer Insights on Healthcare Companies: Adicet Bio (ACET), Ayala Pharmaceuticals (AYLA) and Vaccitech Plc (VACC)NASDAQ:VACCVaccitech PLC
06/06/20224:15PMGlobeNewswire Inc.Vaccitech to Present at the Jefferies Healthcare ConferenceNASDAQ:VACCVaccitech PLC
06/06/20227:30AMGlobeNewswire Inc.Arbutus and Vaccitech Dose First Patient in Phase 2a Clinical Trial Combining Therapies for the Treatment of Chronic Hepatitis B VirusNASDAQ:VACCVaccitech PLC
05/20/202211:30AMGlobeNewswire Inc.Vaccitech to Present at the H.C. Wainwright Global Investment ConferenceNASDAQ:VACCVaccitech PLC
05/17/202212:35PMTipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:VACCVaccitech PLC
05/12/202212:10PMTipRanksAnalysts Are Bullish on Top Healthcare Stocks: BridgeBio Pharma (BBIO), Vaccitech Plc (VACC)NASDAQ:VACCVaccitech PLC
05/11/20224:15PMGlobeNewswire Inc.Vaccitech Reports First Quarter 2022 Financial Results and Recent Corporate DevelopmentsNASDAQ:VACCVaccitech PLC
04/07/20226:25AMTipRanksVaccitech Plc (VACC) Gets a Buy Rating from H.C. WainwrightNASDAQ:VACCVaccitech PLC
04/06/20224:15PMGlobeNewswire Inc.Vaccitech Announces Notification of Milestone and Royalty Revenue Relating to Sales of Vaxzevria®NASDAQ:VACCVaccitech PLC
03/28/20226:25AMTipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:VACCVaccitech PLC
03/25/20227:15AMGlobeNewswire Inc.Vaccitech Reports Full-Year 2021 Financial Results and Recent Corporate DevelopmentsNASDAQ:VACCVaccitech PLC
03/07/20228:00AMGlobeNewswire Inc.Vaccitech to Present at the Barclays Global Healthcare Conference 2022NASDAQ:VACCVaccitech PLC
01/19/20226:22AMTipRanksVaccitech Plc (VACC) Gets a Buy Rating from H.C. WainwrightNASDAQ:VACCVaccitech PLC
01/18/20223:00AMGlobeNewswire Inc.Cancer Research UK Dose First Patient in Phase I/IIa Trial of Lung Cancer Immunotherapy VaccineNASDAQ:VACCVaccitech PLC
01/13/20224:34PMGlobeNewswire Inc.Vaccitech to Host Virtual KOL Event on VTP-300, a Potential Functional Cure for Chronic Hepatitis B (CHB) Infection, and the Broader CHB Therapeutics LandscapeNASDAQ:VACCVaccitech PLC
12/15/20216:25AMTipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Inovio Pharmaceuticals (INO), Allogene Therapeutics (ALLO) and Vaccitech Plc (VACC)NASDAQ:VACCVaccitech PLC
12/13/20214:05PMGlobeNewswire Inc.Vaccitech acquires Avidea Technologies to expand product pipeline and strengthen scientific leadership in immunotherapies and vaccinesNASDAQ:VACCVaccitech PLC
 Showing the most relevant articles for your search:NASDAQ:VACC